Home     |     NAMSA MRO    |     NAMSA Library     |     Contact Us

About the Case Study

By submitting this form, you are providing NAMSA consent to process and store your information.

At any time, you can submit a request to withdraw your consent for the use of information by emailing communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.

Download the Case Study

Solvay Specialty Polymers USA, LLC, a worldwide provider of biomaterials, is the leader in serving diversified markets around the globe. Traditionally, Solvay has been a supplier of biomaterials to the healthcare sector, but recently identified a significant market opportunity within the dental marketplace.

Recognizing a strong need for new and innovative materials within the denture sector, Solvay sought to accurately assess the market opportunity for a polymer solution while also evaluating the associated product development and commercialization requirements, timelines and costs.

To assist with the development of this novel device, Solvay required a clinical research organization (CRO) that possessed vast dental product expertise and also had deep-rooted experience in successfully navigating the U.S. Food & Drug Administration (FDA) 510(k) submission pathway for first-time market entrants.
We invite you to access this case study to learn how NAMSA’s MRO Approach delivered Solvay 12 months and $7.5M in 510(k) development savings.